DHTI · Dalrada Technology Group, Inc. · Financials
$0.02
+0.01 (+87.50%)
At close · Oct 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged May 21, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company continues to incur recurring operating losses, negative cash flows from operations, and significant working capital deficits, which raise substantial doubt regarding the Company's ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued.”View the 10-Q filed May 21, 2026
Market Cap
$1.08M
Shares
120.16M
Volume · Oct 19
37.5K
Avg daily vol (3M)
43.75K
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$20.3M
+2.3%
FY2025
Net Income
-$24.65M
+14.9%
FY2025
Gross Margin
26.11%
+21.2pp
FY2025
Operating Margin
-100.77%
+34.5pp
FY2025
Diluted EPS
-$0.23
+25.8%
FY2025
Operating Cash Flow
-$17.97M
-128.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| $16.51M | $20.3M | $19.84M | $29.74M | $19.27M | $3.41M | $1.18M | $72.16K | $0 | |
| $12.15M | $15M | $18.86M | $20.68M | $8.76M | $2.47M | $625.92K | $75K | $0 | |
| $4.36M | $5.3M | $984.03K | $9.06M | $10.51M | $934.72K | $552.24K | -$2841 | $0 | |
| — | 26.11% | 4.96% | 30.46% | 54.53% | 27.44% | 46.87% | -3.94% | — | |
| $0 | $0 | $0 | $120K | $657K | $520.51K | $471.96K | $50.05K | $0 | |
| $19.56M | $23.02M | $27.82M | $29.47M | $20.07M | $8.98M | $2.77M | $721.85K | $91.98K | |
| $998.04K | $997.28K | $885.97K | $360.54K | $252.94K | $83.61K | $46.6K | $0 | — | |
| $22.29M | $25.76M | $27.82M | $30.02M | $20.94M | $9.5M | $3.24M | $1.04M | $91.98K | |
| -$17.93M | -$20.46M | -$26.84M | -$20.96M | -$10.44M | -$8.57M | -$2.69M | -$1.05M | — | |
| — | -100.77% | -135.26% | -70.48% | -54.16% | -251.57% | -228.25% | -1448.71% | — | |
| -$16.93M | -$19.46M | -$25.95M | -$20.6M | -$10.18M | -$8.49M | -$2.64M | -$1.05M | — | |
| -$3.76M | -$4.2M | $1.24M | $2.55M | $1.3M | $670.27K | $1.04M | $853.18K | $945.24K | |
| $176.15K | $191.86K | $85.66K | $79.76K | $4451 | $6278 | $8769 | $0 | — | |
| -$3.76M | -$4.2M | -$2.34M | $332.24K | -$1M | $8.57M | $211.54K | $1.41M | -$945.24K | |
| -$21.69M | -$24.66M | -$29.18M | -$20.63M | -$11.44M | $1221 | -$2.48M | -$774.74K | -$91.98K | |
| $28.26K | $9600 | $5600 | $0 | $132.51K | $0 | $0 | $0 | $0 | |
| -$21.75M | -$24.65M | -$28.95M | -$20.29M | -$14.1M | $91.43K | -$2.47M | $365.85K | -$1.04M | |
| — | -121.39% | -145.89% | -68.24% | -73.17% | 2.68% | -209.34% | 507.03% | — | |
| $17.22K | -$25.61K | -$237.84K | -$335.2K | $2.53M | -$90.21K | -$11.18K | $0 | — | |
| -$21.3M | -$24.52M | -$29.14M | -$20.63M | -$11.65M | $41.41K | -$2.49M | $365.85K | — | |
| USD/shares | -$0.18 | -$0.23 | -$0.31 | -$0.24 | -$0.20 | $0.00 | -$0.04 | $0.01 | -$0.02 |
| USD/shares | -$0.18 | -$0.23 | -$0.31 | -$0.24 | -$0.20 | $0.00 | -$0.04 | $0.00 | -$0.02 |
| shares | — | 108.49M | 92.24M | 83.76M | 72.22M | 70.32M | 56.8M | 47.43M | 47.28M |
| shares | — | 108.49M | 92.24M | 83.76M | 72.22M | 128.95M | 56.8M | 102.58M | 47.28M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current portion of notes payable | 2026-03-31 | USD 9,143,168 | 10-Q filed 2026-05-21 |
| Current portion of other notes payable | 2026-03-31 | USD 9,143,168 | 10-Q filed 2026-05-21 |
| Noncurrent notes payable | 2026-03-31 | USD 377,827 | 10-Q filed 2026-05-21 |
| Operating lease liabilities | 2026-03-31 | USD 3,228,000 | 10-Q filed 2026-05-21 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Genefic | $10,424,584 | $13,217,899 | $15,740,919 | $13,617,639 | — |
| Dalrada Energy | $8,081,063 | $2,804,236 | $7,075,414 | $1,261,774 | — |
| Dalrada Technologies | $1,348,747 | $1,373,136 | $2,049,411 | $2,239,763 | $1,185,982 |
| Dalrada Precision Manufacturing | $448,409 | $2,447,148 | $4,873,225 | $2,123,437 | $481,313 |
| Corporate | $0 | $0 | $0 | $25,000 | — |
| Dalrada Health | — | — | — | — | $1,739,389 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| United States | $17,410,789 | $17,194,741 | $26,208,432 | $16,536,221 | $1,889,449 |
| Spain | $1,541,380 | $310,568 | $0 | — | — |
| India | $970,053 | $1,094,468 | $1,643,476 | $2,005,949 | $1,185,981 |
| United Kingdom | $380,581 | $1,242,642 | $1,887,061 | $725,443 | $321,254 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Unrelated Parties | $18,622,330 | $18,124,587 | — | — | — |
| Service Revenue Third Parties | $11,887,749 | $4,207,133 | — | $15,584,154 | $2,020,307 |
| Healthcare Insurers Government Payers And OTC Pharmaceutical Sales | $8,431,233 | $11,745,574 | $12,546,849 | — | — |
| Product Sales Third Parties | $6,812,477 | $13,917,454 | — | $2,280,403 | $1,053,720 |
| Related Parties | $1,680,473 | $1,717,832 | — | — | — |
| Service Revenue Related Party | $1,602,577 | $1,717,692 | $2,205,438 | $1,327,732 | $270,050 |
| Product Sales Related Party | $0 | $140 | — | — | — |
| Healthcare Insurers and Government Payers | — | — | $12,546,849 | $11,824,717 | — |
| Healthcare Insurers | — | — | — | $11,824,717 | — |
| Product Sales Related Parties | — | $140 | $77,308 | $75,324 | $62,607 |
| Revenues | — | — | — | $17,864,557 | — |
| Revenues Related Party | — | — | — | $1,403,056 | — |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Dalrada Technologies | -$62,001 | -$235,104 | $10,634 | $30,177 | -$276,385 |
| Dalrada Energy | -$2,864,224 | -$6,314,398 | — | $967,639 | — |
| Genefic | -$3,617,277 | -$6,611,308 | -$5,783,441 | $2,225,304 | — |
| Dalrada Precision Manufacturing | -$4,006,023 | -$1,349,321 | -$2,461,219 | -$2,834,342 | -$2,024,154 |
| Corporate | -$9,909,185 | -$12,329,215 | -$11,660,710 | -$10,824,022 | -$4,942,487 |
| Dalrada Climate Technology and Dalrada Energy | — | — | -$1,065,221 | — | — |
| Dalrada Health | — | — | — | — | -$1,327,125 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Genefic | -34.7% | -50% | -36.7% | 16.3% | — |
| Dalrada Energy | -35.4% | -225.2% | — | 76.7% | — |
| Dalrada Technologies | -4.6% | -17.1% | 0.5% | 1.3% | -23.3% |
| Dalrada Precision Manufacturing | -893.4% | -55.1% | -50.5% | -133.5% | -420.5% |
| Corporate | — | — | — | -43296.1% | — |
| Dalrada Health | — | — | — | — | -76.3% |